Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ADMed Oy
OY
Active
Y-tunnus 3178529-3
Trillakatu 4
General medical practice activities · NACE 8621
Est. 2020
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
EUR 0
EBITDA margin
—
-111% vs 2024
Equity ratio
97.4%
Financial strength
Net profit 2025
EUR -16K
+81% vs 2024
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
EUR 0
—
EBITDA
EUR -12K
-111%
Net profit
EUR -16K
+81%
Total assets
EUR 44K
-35%
Equity
EUR 43K
-33%
Employees
1
—
Company information
Legal name
ADMed Oy
Y-tunnus number
3178529-3
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
19. joulukuuta 2020
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Terveydenhuolto
Contact
Address
Trillakatu 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Espoo
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
207
190
697
—
0
Staff expenses
−59
−38
−192
87
−3
EBITDA
144
59
90
112
−12
Depreciation & amort.
—
—
−6
4
−3
EBIT
144
59
84
−85
−16
Net financials
−0
−0
−0
—
−0
Profit before tax
144
59
84
−85
−16
Tax
29
13
19
−0
−0
Net profit
115
46
65
−85
−16
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
124
194
21 226
68
44
Equity
115
139
19 300
64
43
Long-term debt
—
—
0
—
0
Short-term debt
9
55
1 926
4
1
Total debt
9
55
1 926
4
1
Financial ratios
5-year trend
EBITDA margin
-1237600.0%
This company
15.8%
Market median
-7833011% vs market
2021
2025
Equity ratio
97.4%
This company
38.2%
Market median
+155% vs market
2021
2025
Return on equity
-36.9%
This company
18.4%
Market median
-301% vs market
2021
2025
Net profit margin
-1575000.0%
This company
8.1%
Market median
-19444544% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-12-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AM
Abdihakiim Mohamed Dinbil
Chief Executive Officer
Chief Executive Officer
2021
HM
Halimo Mohamed Abdi
Deputy Member
Deputy Member
2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ADMed Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Abdihakiim Mohamed Dinbil
Chief Executive Officer
0 companies
Halimo Mohamed Abdi
Deputy Member
0 companies